Learn about the unique role of Lp(a) as a genetic determinant for #ASCVD risk & the importance of testing for Lp(a) levels to better understand your patients’ cardiovascular health w/ ACC's online course. ⬇️
More: https://t.co/OY9j8lZRfI
#LpaAwarenessDay#KnowLpa#ACCEd
five studies I would put at the top of the ACC.26 March 28–30, 2026, in New Orleans
1.CHAMPION-AF — primary results comparing left atrial appendage closure vs oral anticoagulation in patients with atrial fibrillation.
2.STEMI-Door to Unload — results of primary left ventricular unloading in anterior STEMI without cardiogenic shock
3.Spironolactone in the Treatment of Heart Failure
4.TAVI Without Routine PCI — a randomized trial testing transcatheter aortic valve implantation without routine percutaneous coronary intervention.
5.Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction
#ACC26 #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare
@JACCJournals@ACCinTouch@DrMarthaGulati@hvanspall@BiykemB@ankeetbhatt@ShelleyZieroth@Hragy@cardioceptor
https://t.co/qdUNXUfOEl
Hi Everyone -
🥸Here are all the 27 late breaking clinical trials presented at @ACCinTouch (ACC.26) with session number, day, time, and objective.
😱See you in NOLA:
👇👇👇
Female gender was removed from CHADS-VASc score in new ESC guidelines for management of AF.
Rationale : female gender is a risk modifier rather than risk factor for stroke.
Now we have a CHADS-VA score.
Beyond excited to join the @advocatehealth@immc_imresident for my residency! 🎉 💜
I' m so grateful for the fantastic support from my fam, friends, and mentors, who’ve been my rock through everything!
I’m going to Chicago 🥹🙏🏼🏙️🌟
Hi #MedTwitter, I'm Alexandra, an IMG from Paraguay🇵🇾, applying to Internal Medicine for #Match2024.
My interests include preventative & integrative medicine, and health equity.
Excited for what's ahead and looking forward to getting to know fellow applicants and programs!